menu search

Why shares of carnival corporation declined by 20.5% in november

The cruise company could see a resumption in bookings if the omicron variant turns out to be less severe...

December 8, 2021, 9:13 pm

Why shares of carnival corporation declined by 20.5% in november

The cruise company could see a resumption in bookings if the omicron variant turns out to be less severe...

December 8, 2021, 9:13 pm

Don't bet on a deciphera stock comeback

Qinlock's potential is severely limited, and the rest of Deciphera's pipeline is far from the commercia...

November 30, 2021, 1:16 pm

Don't bet on a deciphera stock comeback

Qinlock's potential is severely limited, and the rest of Deciphera's pipeline is far from the commercia...

November 30, 2021, 1:16 pm

Don't bet on a deciphera stock comeback

Qinlock's potential is severely limited, and the rest of Deciphera's pipeline is far from the commercia...

November 30, 2021, 1:16 pm

G1 therapeutics has some hot irons in the fire: it might be time to buy

G1 Therapeutics is currently facing some pretty severe market penalties, considering they have a drug a...

November 22, 2021, 9:11 pm

G1 therapeutics has some hot irons in the fire: it might be time to buy

G1 Therapeutics is currently facing some pretty severe market penalties, considering they have a drug a...

November 22, 2021, 9:11 pm

G1 therapeutics has some hot irons in the fire: it might be time to buy

G1 Therapeutics is currently facing some pretty severe market penalties, considering they have a drug a...

November 22, 2021, 9:11 pm

Synaptogenix: high-risk high-reward for potential alzheimer's disease treatment

SNPX did not achieve primary endpoints in two Phase 2 studies for Bryostatin for the treatment of Alzheimer's Disease in moderately...

November 16, 2021, 11:07 pm

Synaptogenix: high-risk high-reward for potential alzheimer's disease treatment

SNPX did not achieve primary endpoints in two Phase 2 studies for Bryostatin for the treatment of Alzheimer's Disease in moderately...

November 16, 2021, 11:07 pm

Synaptogenix: high-risk high-reward for potential alzheimer's disease treatment

SNPX did not achieve primary endpoints in two Phase 2 studies for Bryostatin for the treatment of Alzheimer's Disease in moderately...

November 16, 2021, 11:07 pm

Singles day beckons for em e-commerce etf

China's Singles Day, one of the world's largest retail events, arrives Thursday. Against the backdrop of heavy regulatory scrutiny that resulted in...

November 10, 2021, 1:31 pm

Singles day beckons for em e-commerce etf

China's Singles Day, one of the world's largest retail events, arrives Thursday. Against the backdrop of heavy regulatory scrutiny that resulted in...

November 10, 2021, 1:31 pm

Singles day beckons for em e-commerce etf

China's Singles Day, one of the world's largest retail events, arrives Thursday. Against the backdrop of heavy regulatory scrutiny that resulted in...

November 10, 2021, 1:31 pm

Argenx to present at upcoming investor conferences

November 10, 2021 Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people ...

November 10, 2021, 1:00 am

Argenx to present at upcoming investor conferences

November 10, 2021 Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people ...

November 10, 2021, 1:00 am

Argenx to present at upcoming investor conferences

November 10, 2021 Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people ...

November 10, 2021, 1:00 am

Britain approves first oral covid-19 antiviral from merck

The United Kingdom Medicines and Healthcare products Regulatory Agency (MHRA) has granted authorization to Merck & Co Inc (NYSE: MRK) and Ridgeba...

November 4, 2021, 6:56 am

Britain approves first oral covid-19 antiviral from merck

The United Kingdom Medicines and Healthcare products Regulatory Agency (MHRA) has granted authorization to Merck & Co Inc (NYSE: MRK) and Ridgeba...

November 4, 2021, 6:56 am

Britain approves first oral covid-19 antiviral from merck

The United Kingdom Medicines and Healthcare products Regulatory Agency (MHRA) has granted authorization to Merck & Co Inc (NYSE: MRK) and Ridgeba...

November 4, 2021, 6:56 am


Search within

Pages Search Results: